BioMarin Pharmaceutical Inc. buy Wells Fargo & Company
Start price
15.11.23
/
50%
€80.32
Target price
15.11.24
€92.05
Performance (%)
-11.21%
Price
17.05.24
€71.32
Summary
This prediction is currently active. The prediction for BioMarin Pharmaceutical Inc. disappoints with a performance of -11.21%. This prediction currently runs until 15.11.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
BioMarin Pharmaceutical Inc. | -6.355% | -6.355% |
iShares Core DAX® | -0.383% | 5.021% |
iShares Nasdaq 100 | 1.248% | 4.007% |
iShares Nikkei 225® | 0.525% | -0.109% |
iShares S&P 500 | 0.640% | 3.649% |
Comments by Wells_Fargo___Compan for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $100.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€77.00
25.04.24
25.04.24
€102.63
25.04.25
25.04.25
-7.38%
17.05.24
17.05.24